Skip to content

LifeMD, Inc. LFMD Treasury Stock

Treasury Stock at other companies

CVS Health logo
CVS HealthCVS
$36.71B-0.1%
Scilex Holding Company logo
Scilex Holding CompanySCLX
$76.92M0.0%
Opko Health logo
Opko HealthOPK
$1.79M0.0%
Cencora logo
CencoraCOR
$10.44B+1.0%

Other financials

Income statement

See full
Revenue$50.2M-1.4%
Gross profit$44.2M+3.5%
Operating income-$8.9M-656%
Net income-$8.9M-4,728%
EPS (diluted)-$0.20-900%

Balance sheet

See full
Cash & equivalents$34.5M+7.9%
Total debt$6.2M-76.9%
Total equity$15.0M+746%
Total assets$70.1M-4.7%

Cash flow

See full
Operating cash flow$444.6K-85.5%
CapEx$105.2K-10.5%
Free cash flow$339.4K-88.5%

Valuation

See full
Market cap$235.53M-61.7%
Enterprise value$207.22M-66.2%
P/E41.6×
P/S1.3×-2.3×

Profitability

See full
Gross margin86.1%+0.9pp
Operating margin-9.8%-0.9pp
Net margin3.1%+1.8pp
FCF margin10.4%+1.7pp

Returns & leverage

See full
Return on equity-393.6%
Debt / equity0.4×
Current ratio+0.2×

Where this comes from

Reported directly by LifeMD, Inc. in its filing.

Tagged under the XBRL concept us-gaap:TreasuryStockValue.

The official record: LifeMD, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LifeMD, Inc.'s treasury stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LifeMD, Inc.'s treasury stock?
LifeMD, Inc. (LFMD) reported treasury stock of $163.7K in Q1 2026.
How has LifeMD, Inc.'s treasury stock changed year-over-year?
LifeMD, Inc.'s treasury stock decreased by 0.0% year-over-year, from $163.7K to $163.7K.
What is the long-term trend for LifeMD, Inc.'s treasury stock?
Over 5 years (2020 to 2025), LifeMD, Inc.'s treasury stock has grown at a 0.0% compound annual growth rate (CAGR), from $163.7K to $163.7K.
What does treasury stock mean?
Shares repurchased by the company and held in treasury, reducing equity. Recorded at cost and presented as a negative equity component.